CANNABICS PHARMACEUTICALS INC has a total of 23 patent applications. It increased the IP activity by 25.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and computer technology are ZIEGLER RANDY H, CENTOGENE IP GMBH and CENTRAL ADELAIDE LOCAL HEALTH NETWORK INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | Israel | 3 | |
#5 | Japan | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hong Kong | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Computer technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Ballan Eyal | 18 |
#2 | Borochov Itamar | 6 |
#3 | Grinberg Moran | 5 |
#4 | Eyal Ballan | 5 |
#5 | Sarid Shay Avraham | 2 |
#6 | Koren Zohar | 2 |
#7 | Itamar Borochov | 1 |
Publication | Filing date | Title |
---|---|---|
US2019134123A1 | Novel system and method for microbiome profiling and modulation by means of cannabis administration | |
US2020408740A1 | Method for sensitivity testing of cannabinoids on patientderived tumor biopsies and ctcs | |
CN108027372A | System and method for high flux screening cancer cell | |
IL244278D0 | Cannabinoid compositions, methods of manufacture and use thereof | |
US2015057342A1 | Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof |